Company intelligence / Profile preview

RareCyte

Seattle, Washington, United Statesrarecyte.com ↗

Ownership: Private
Development stage: Commercial

Overview

RareCyte provides advanced platforms for spatial biology imaging and liquid biopsy analysis. Their Orion platform enables high-speed multiplexed immunofluorescence imaging for cellular phenotyping. The company supports discovery through translational research to clinical diagnostics with end-to-end solutions including custom assay development, CLIA-certified lab testing, companion diagnostic development partnerships, and global CRO collaborations. No therapeutics or drugs are in their pipeline as they focus on enabling technologies rather than direct drug development

Therapeutic areas: OtherOncology
Modalities: DeviceDiagnostic assayProtein-based assay
Industry: Medical Imaging

Partnerships

Partnerships with global IVD manufacturers for companion diagnostics developmentNetwork of Qualified Service Providers including global CROs supporting clinical studies

Beyond the preview

Go deeper on RareCyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RareCyte.

Explore the full profile